ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

ACCC’s Landmark Cancer Community Survey Turns 10

January 28, 2020

ACCC’s Landmark Cancer Community Survey Turns 10

Now in its 10th year, ACCC’s Trending Now in Cancer Care survey continues to bring into focus the proactive and reactive responses of cancer programs to shifts in the business of cancer care delivery. As they have throughout the past decade, in 2019, survey respondents nationwide told ACCC how they are handling the intersecting levers of change that continue to buffet oncology care. As developments in science, business, industry, policy, and patient and provider concerns continue to evolve, ACCC’s Trending Now survey helps clarify the most relevant challenges and opportunities facing the cancer care community.

Conducted by ACCC in partnership with the Advisory Board’s Oncology Roundtable, the 2019 survey was distributed via email in fall 2019 and received 144 responses from individuals at 126 organizations. Despite a volatile reimbursement climate and the challenges that accompany value-based care models, cancer programs continue to find innovative ways to meet a rising demand for patient-centered care.

Cancer practices say the top three services or programs they plan to add or grow this year are survivorship visits or clinics, palliative care consults, and navigation. Additional plans to grow services in genetic counseling, oral chemotherapy adherence and support, and financial advocacy indicate an ongoing demand for comprehensive cancer care.

Top Challenges: Payer Reimbursement, Value-Based Care

When asked to identify the top threats to future cancer program growth, nearly half of respondents (49 percent) cited payer reimbursement requirements (slightly up from 48 percent in 2018). The shift of reimbursement from fee-for-service to value-based care ranked second (48 percent; up from 30 percent in 2018). Also of concern are uncertainties in drug pricing reform policies (40 percent) and the cost of new treatment processes and equipment (37 percent). Notably, the cost of drugs as a top concern was down from 48 percent in 2018 to 34 percent in 2019.

Top Cost-Saving Opportunities: Care Coordination, Symptom Management

For many cancer programs, expanding supportive care service lines is often paid for by cost-savings or cost-containment efforts. Asked to identify the top opportunities for cost savings, a significant majority of respondents (88 percent) named improving care coordination, up significantly from 41 percent in 2018. Eighty-five percent of respondents named improving symptom management as a cost-savings opportunity, compared to 54 percent in 2018. Seventy-six percent of respondents said using lower-cost drugs was a cost-savings prospect for them, up from 42 percent in 2018.

Survey highlights

  • Workplace concerns: With burnout prevalent among healthcare workers, survey respondents cited a number of workplace concerns:
    • Workflow inefficiencies (75 percent)
    • Heavy workloads (58 percent)
    • Staff complaints about workload and burnout (58 percent)
    • Lack of work/life balance (40 percent)
    • Decreasing focus on patient care (24 percent)
  • Telehealth: Survey results revealed limited adoption of telehealth in cancer care delivery. Asked to name the top four services they currently provide via telehealth, respondents cited tumor boards (45 percent), genetic counseling (32 percent), molecular tumor boards (24 percent), and second opinions (16 percent). A number of respondents say they plan to leverage telehealth for multiple services during the next two years, including:
    • Genetic counseling (35 percent)
    • Symptom management consults (28 percent)
    • Oral chemotherapy adherence and support (28 percent)
    • Symptom monitoring (28 percent)
    • Psychosocial counseling (24 percent)
    • Nutrition counseling (22 percent)
    • Financial navigation (21 percent)
    • Survivorship visits (21 percent)
    • Tumor boards (21 percent)
  • Staffing needs: Retaining adequate staff to ensure access to quality care for all patients is an ongoing challenge. The positions cancer programs report being most concerned about filling are medical oncologists (59 percent), oncology nurses (53 percent), financial advocacy staff (49 percent), navigators (44 percent), and palliative care specialists (43 percent).
  • Clinical trials: Survey results reveal a number of ongoing challenges to offering patients access to clinical trials. More than half (53 percent) cite inadequate staff resources and training, 50 percent cite inadequate program infrastructure, and 46 percent cite lack of patient understanding of the clinical trial process.

During the past decade, ACCC’s Trending Now in Cancer Care survey has provided an annual comprehensive picture of the evolution of cancer services and care delivery at programs and practices nationwide. While some concerns have resolved with time, others remain as intractable as ever. As oncology care enters the third decade of the new millennium, the Trending Now survey will continue to take the pulse of the provider community. ACCC President Ali McBride, PharmD, MS, BCOP, calls the annual survey, “a real-world reference point that cancer programs large and small can utilize as they navigate the multisector changes in healthcare.”

Related Content

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung CancerACCCBuzz Blog

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

April 24, 2026

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and OmniscopeACCCBuzz Blog

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

Rachel Radwan

April 22, 2026

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership SummitACCCBuzz Blog

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Gabrielle Stearns

April 20, 2026

Bispecific Antibodies Are Moving Forward; So Are the Implementation QuestionsACCCBuzz Blog

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

Rifeta Kajdić Hodžić

April 17, 2026

Highlights From Volume 41, Number 2 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 2 Oncology Issues

Gabrielle Stearns

April 15, 2026

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual ConferenceACCCBuzz Blog

Developing Clinical Insight, Professional Competencies, and Strategic Awareness: NCCN 2026 Annual Conference

Rachel Radwan; Gabrielle Stearns

April 8, 2026

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREFACCCBuzz Blog

Representing Veterans in Clinical Trials Through Public-Private Partnerships: A Q&A With NAVREF

Gabrielle Stearns

March 26, 2026

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better OutcomesACCCBuzz Blog

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better Outcomes

Rachel Radwan

March 25, 2026

Upcoming Events

ACCC Oncology Reimbursement Meeting | Charleston
Oncology

ACCC Oncology Reimbursement Meeting | Charleston

In Person Meeting & NetworkingMay 6, 2026 at 8:00 AM EDT560 King Street, Charleston, SC, USAHyatt Place + Hyatt House Charleston - Historic District, Charleston
Register Now!
ACCC Oncology Reimbursement Meeting | St. Louis
Oncology

ACCC Oncology Reimbursement Meeting | St. Louis

In Person Meeting & NetworkingMay 13, 2026 at 8:00 AM CDT1335 South Lindbergh Boulevard, St. Louis, MO, USAHilton St. Louis Frontenac, St. Louis
Register Now!
ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
Precision in Practice: Translating MRD Into Oncology Care
Oncology

Precision in Practice: Translating MRD Into Oncology Care

In Person Conference & ConventionApril 28, 2026 at 5:30 PM EDT1020 South Calhoun Street, Fort Wayne, IN, USAHilton Fort Wayne at the Grand Wayne Center, Fort Wayne
Register Now!
MOS 2026 Spring Conference
Oncology

MOS 2026 Spring Conference

In Person Conference & ConventionApril 28, 2026 at 5:15 PM CDT1111 East Broadway, Columbia, MO, USAThe Broadway Columbia (A DoubleTree by Hilton), Columbia
Register Now!
RIOS 2026 Spring Symposium
Oncology

RIOS 2026 Spring Symposium

In Person Conference & ConventionMay 9, 2026 at 11:00 AM EDT4 Richmond Square, Providence, RI 02906, USAWaterman Grille, Providence
Register Now!
 HSCO 2026 May Dinner Symposium
Oncology

HSCO 2026 May Dinner Symposium

In Person Conference & ConventionMay 13, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
WSOS 2026 Laramie Meeting
Oncology

WSOS 2026 Laramie Meeting

In Person Conference & ConventionMay 20, 2026 at 5:30 PM MDT222 South 22nd Street, Laramie, WY, USAUniversity of Wyoming – Rochelle Gateway Center, Laramie
Register Now!
IOS 2026 Welcome Reception
Oncology

IOS 2026 Welcome Reception

In Person Conference & ConventionMay 30, 2026 at 6:00 PM CDT1060 West Addison Street, Chicago, IL, USAWrigley Field, Chicago
Register Now!
WAHO 2026 Welcome Reception
Oncology

WAHO 2026 Welcome Reception

In Person Conference & ConventionMay 30, 2026 at 6:00 PM CDT1060 W Addison St, Chicago, IL, USAWrigley Field , Chicago
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

Small Cell SMASHERS: How Community, Advocacy, and Emerging Science Are Changing the Narrative in Small Cell Lung Cancer

Small Cell SMASHERS was founded in 2023 as a patient-centered advocacy and education community designed to challenge long-standing narratives about small cell lung cancer and restore a sense of voice, connection, and hope for patients and their loved ones.

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

Partnering to Deliver Targeted Treatment: Fox Chase Cancer Center and Omniscope

ACCCBuzz spoke with Fox Chase Cancer Center to learn more about its partnership with Omniscope, a leader in advanced molecular profiling technology, in hopes of developing an assay that accurately predicts which patients will respond well to immunotherapy based on the presence of certain T-cell clones.

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

Innovation, Policy, and Partnership: Key Takeaways From the Inaugural ACCC Leadership Summit

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

Bispecific Antibodies Are Moving Forward; So Are the Implementation Questions

During the HOPA 2026 annual conference, ACCC brought together a small group of oncology pharmacists for a practical, candid conversation about challenges with the implementation of bispecific antibodies that was deeply grounded in real-world experience and what it takes to operationalize care.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Innovation in Action: Breaking Down the 2025 ACCC Impact Report – [Mini Podcast] Ep. 228

Transforming Palliative Care in Oncology – [Video Podcast] Ep. 227

Streamlining Access to TIL Cell Therapy for Melanoma – [Podcast] Ep. 226

Policy in Practice: Change Hits the Clinic – [Podcast] Ep. 225

View All Podcasts

Latest from Oncology Issues

April 2026
April 2026
February 2026
December 2025
October 2025
August 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login